Frontlight ResearchEarly access
Trial site
Xi'an Gaoxin Hospital
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Stroke3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Colorectal cancer1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Myasthenia gravis1 trial
- Myotonic dystrophy1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- argenx1 trial
- Huashan Hospital1 trial
- Janssen Research & Development, LLC1 trial
- NewAmsterdam Pharma1 trial
- Shanghai Pharmaceuticals Holding Co., Ltd1 trial
- and 5 more
Running trials
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Recruiting
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Enrolling by invitation
Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Myotonic dystrophy1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026